Skip to product information
1 of 1

Elabscience

SKU:E-AB-F1122B-50μg

Biotin Anti-Mouse CD45.2 Antibody[104.2]

Biotin Anti-Mouse CD45.2 Antibody[104.2]

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
The BIOTIN ANTI-MOUSE CD45.2 ANTIBODY[104.2] is a highly specific and reliable tool designed for the detection and analysis of CD45.2 expression in mouse samples. This antibody is conjugated with biotin, allowing for easy and efficient detection using streptavidin-based detection systems.

CD45.2, also known as leukocyte common antigen (LCA), is a transmembrane protein expressed on all nucleated hematopoietic cells. It plays a crucial role in the regulation of immune responses and cell signaling. The BIOTIN ANTI-MOUSE CD45.2 ANTIBODY[104.2] specifically recognizes the CD45.2 isoform, enabling precise identification and characterization of CD45.2-positive cells.

This antibody has been extensively validated for various applications, including flow cytometry, immunohistochemistry, and immunofluorescence. It exhibits exceptional sensitivity and specificity, ensuring accurate and reproducible results. The BIOTIN ANTI-MOUSE CD45.2 ANTIBODY[104.2] is suitable for both research and diagnostic purposes, providing valuable insights into immune cell populations and their functions.

With its high affinity and low background staining, this antibody offers excellent performance in a wide range of experimental settings. It is manufactured under strict quality control standards to ensure batch-to-batch consistency and reliability. The BIOTIN ANTI-MOUSE CD45.2 ANTIBODY[104.2] is supplied in a convenient format, allowing for easy handling and storage.

In summary, the BIOTIN ANTI-MOUSE CD45.2 ANTIBODY[104.2] is a superior reagent for the detection and analysis of CD45.2 expression in mouse samples. Its exceptional specificity, sensitivity, and versatility make it an indispensable tool for researchers and clinicians studying immune cell biology and related diseases.
View full details